3f5p

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
{{Seed}}
{{Seed}}
-
[[Image:3f5p.jpg|left|200px]]
+
[[Image:3f5p.png|left|200px]]
<!--
<!--
Line 18: Line 18:
-->
-->
{{ABSTRACT_PUBMED_19041240}}
{{ABSTRACT_PUBMED_19041240}}
- 
-
==Disease==
 
-
Known disease associated with this structure: Intrauterine and postnatal growth retardation OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=147370 147370]]
 
==About this Structure==
==About this Structure==
-
3F5P is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3F5P OCA].
+
3F5P is a 16 chains structure with sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3F5P OCA].
==Reference==
==Reference==
-
Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment., Miller LM, Mayer SC, Berger DM, Boschelli DH, Boschelli F, Di L, Du X, Dutia M, Floyd MB, Johnson M, Kenny CH, Krishnamurthy G, Moy F, Petusky S, Tkach D, Torres N, Wu B, Xu W, Bioorg Med Chem Lett. 2009 Jan 1;19(1):62-6. Epub 2008 Nov 17. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/19041240 19041240]
+
<ref group="xtra">PMID:19041240</ref><ref group="xtra">PMID:18501599</ref><references group="xtra"/>
-
 
+
-
Lead identification to generate isoquinolinedione inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment., Mayer SC, Banker AL, Boschelli F, Di L, Johnson M, Kenny CH, Krishnamurthy G, Kutterer K, Moy F, Petusky S, Ravi M, Tkach D, Tsou HR, Xu W, Bioorg Med Chem Lett. 2008 Jun 15;18(12):3641-5. Epub 2008 Apr 25. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/18501599 18501599]
+
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Receptor protein-tyrosine kinase]]
[[Category: Receptor protein-tyrosine kinase]]
-
[[Category: Single protein]]
+
[[Category: Berger, D M.]]
-
[[Category: Pdbx_ordinal=, <PDBx:audit_author.]]
+
[[Category: Boschelli, D H.]]
 +
[[Category: Boschelli, F.]]
 +
[[Category: Mayer, S C.]]
 +
[[Category: Miller, L M.]]
 +
[[Category: Xu, W.]]
[[Category: Atp-binding]]
[[Category: Atp-binding]]
[[Category: Cleavage on pair of basic residue]]
[[Category: Cleavage on pair of basic residue]]
Line 49: Line 48:
[[Category: Tyrosine-protein kinase]]
[[Category: Tyrosine-protein kinase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 7 20:04:46 2009''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Sep 22 11:51:46 2010''

Revision as of 08:42, 22 September 2010

Template:STRUCTURE 3f5p

Complex Structure of Insulin-like Growth Factor Receptor and 3-Cyanoquinoline Inhibitor

Template:ABSTRACT PUBMED 19041240

About this Structure

3F5P is a 16 chains structure with sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

  • Miller LM, Mayer SC, Berger DM, Boschelli DH, Boschelli F, Di L, Du X, Dutia M, Floyd MB, Johnson M, Kenny CH, Krishnamurthy G, Moy F, Petusky S, Tkach D, Torres N, Wu B, Xu W. Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment. Bioorg Med Chem Lett. 2009 Jan 1;19(1):62-6. Epub 2008 Nov 17. PMID:19041240 doi:S0960-894X(08)01390-5
  • Mayer SC, Banker AL, Boschelli F, Di L, Johnson M, Kenny CH, Krishnamurthy G, Kutterer K, Moy F, Petusky S, Ravi M, Tkach D, Tsou HR, Xu W. Lead identification to generate isoquinolinedione inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment. Bioorg Med Chem Lett. 2008 Jun 15;18(12):3641-5. Epub 2008 Apr 25. PMID:18501599 doi:10.1016/j.bmcl.2008.04.044

Page seeded by OCA on Wed Sep 22 11:51:46 2010

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools